Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 2	2024-07-08		NCT06489808

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institute of Hematology & Blood Diseases Hospital, China	285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of Hematology & Blood Disease Hospital	Tianjin	China	2

Clinical trials